comprehensive -WSS

comprehensive

author：knowledge 2025-10-02 14:22:51 - browse：99

Sage Therapeutics, a biotech developing an experimental treatment for postpartum depression, this week trumpeted strong results from a clinical trial, which cheered investors and pushed up its stock price. But outside the lab, the company’s aggressive efforts to raise awareness of postpartum depression have proved divisive.

The campaign’s message: “When it comes to postpartum depression, silence sucks.” It features close-up photos of distressed, tearful women who can’t speak — because they have pacifiers stuck in their mouths.

The images have been plastered on bus stops, buses, conference booths, and on a dedicated website. The ads don’t specifically mention Sage’s drug, which still needs further testing before the company can bring it to the Food and Drug Administration for possible approval. Instead, they urge women to talk “openly and honestly” about postpartum depression. An estimated 600,000 women in the U.S. alone experience symptoms, which range from insomnia and irritability to difficulty bonding with their baby.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Anesthesiologist group: stop taking Ozempic before surgery
Next article： Goldman Sachs launches $650M fund for life science investments

focus

WSS

Experimental asthma app from Apple and Anthem shows promise

Experimental asthma app from Apple and Anthem shows promise

Readout Newsletter: Novo Nordisk trial, Verve base editing, etc

Medical school prerequisites are outdated

Medical school prerequisites are outdated

The FDA must approve intranasal treatments for anaphylaxis

hotspot

comprehensive

leisure time

New air purifier tech could be key to improving indoor air quality

How state and local governments are sidelining science

Activists slam private health insurers over coverage restrictions

Study suggests Covid rebound is far more common with Paxlovid than without

ChatGPT in medicine: STAT answers readers' burning questions

NIH chief: government has fallen behind pharma on clinical trials

Guidelines to prevent youth baseball injuries need more muscle

What health policies could hitch a ride on a spending bill?

Jerome Adams on the need for new antivirals for Covid

Today's health inequities arise from racist U.S. history, say experts

hotspot

At JPM, Bristol Myers Squibb CEO tries to soothe investor nerves

How a scoliosis diagnosis changed the life of one young dancer

At JPM, Bristol Myers Squibb CEO tries to soothe investor nerves

How a scoliosis diagnosis changed the life of one young dancer

JPM: CVS says Medicare Advantage patients are impacting profits

Eli Lilly’s chief scientist on obesity drugs, gene editing, and more

entertainment

leisure time

focus

hotspot